News

5 Revealing Analyst Questions From Biogen’s Q2 Earnings Call

Biogen’s second quarter delivered results that exceeded Wall Street’s revenue and profit expectations, a performance that was ...

BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance

Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.3% year on year to ...
Pharmabiz43m

Biogen and Stoke Therapeutics dose first patient in global phase 3 EMPEROR study of zorevunersen to treat Dravet syndrome

Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...